Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-03-24
1983-07-19
Waltz, Thomas A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2605005H, 424315, 424317, 424324, 560 72, 564177, 564179, A61K 31235, A61K 31185, C07C10326, C07C 6978
Patent
active
043943896
ABSTRACT:
Di and trihydroxybenzohydroxamic acids, amides, alkyl substituted amides and phenyl esters, ribonucleotide reductase inhibitors.
REFERENCES:
patent: 2849480 (1958-08-01), Krenchmann
patent: 4263322 (1981-04-01), van't Riet et al.
Child et al., CA 76:43275e (1972).
Gale, Proc. Soc. Exptl. Biol. Med., 122 1236 (1966).
Gale & Hynes, J. Med. Chem., 11, 191 (1968).
Howle & Gale, Proc. Soc. Exptl. Biol. Med., 131, 697 (1969).
Gale, Hynes & Smith, J. Med. Chem., 14, 571 (1970).
Gale & Carnes, Clin. Pharm. 20, 2677 (1971).
CA 85, 94115 (1976).
CA 81, 120190f (1974).
CA 74, 112752f (1971).
Elford et al., Can. Res., 39, 844 (1979).
van't Riet et al., J. Med. Chem., 22, 589 (1979).
Elford et al., AACR Abstracts 601 Mar. 1979.
Elford AACR Abstracts 707 Mar. 1977.
Elford et al., AACR Abstracts 250 Mar. 1978.
Elford Howard L.
van't Riet Bartholomeus
Wampler Galen L.
Rowe James L.
Waltz Thomas A.
Whale Arthur R.
LandOfFree
Hydroxybenzohydroxamic acids, benzamides and esters as ribonucle does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxybenzohydroxamic acids, benzamides and esters as ribonucle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxybenzohydroxamic acids, benzamides and esters as ribonucle will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-751452